Sublingual Immunotherapy (SLIT): Current Perspectives
Monday, February 23, 2015: 10:45 AM-12:00 PM
Convention Center, Level Three, Grand Ballroom B
1.25 CME/ 1.50 CE
David P. Skoner , MD

Learning Objectives

  1. Describe the underlying mechanisms and actions of sublingual immunotherapy (SLIT) constructs
  2. Identify how to properly evaluate and determine the maintenance treatment dose, the duration of therapy and the components of treatment when using SLIT
  3. Discuss how to initiate appropriate treatment with the relevant therapeutic constructs that have recently received regulatory approval for use in the practice setting
10:45 AM
Long-Term Clinical Outcomes with SLIT
Ronald Dahl, MD
11:05 AM
Latest Clinical Findings in SLIT: Clinical Efficacy, Safety and Dosing Regimens
Linda Cox, MD FAAAAI
11:25 AM
When to Consider SLIT vs. SCIT
Désirée E.S. Larenas Linnemann, MD FAAAAI
11:45 AM
Question & Answer
See more of: Symposia